Facilities

Production of tree-saving transformative vaccine adjuvant with in-lab plants

17-Apr-2024 By Liza Laws

During DCAT this year, CEO Gaston Salinas from Botanical Solution Inc., (BSI), sat down with Liza Laws, the senior editor of OSP and BPR to discuss his company’s pioneering work in revolutionizing vaccine adjuvant production.

Symbiosis Pharmaceutical Services granted MHRA license following £1 million investment

07-Dec-2023 By Liza Laws

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a £1 million investment.

Lilly's plans for $2.5 billion site in Germany to expand injectable manufacturing capacity

06-Dec-2023 By Liza Laws

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.

Aragen launches $30 million biologics manufacturing facility

02-Nov-2023 By Jonathan Smith

The Indian contract research development and manufacturing organization (CRDMO) Aragen Life Sciences will invest $30 million in building a 160,000 square-meter biologics manufacturing facility in Bangalore.

eXmoor pharma unveils new manufacturing facility in Bristol

12-Oct-2023 By Isabel Cameron

eXmoor pharma has opened the doors to its new cell and gene therapy centre GMP facility, based in Bristol, UK.

Evolve Biologics $200m Texas facility set for 2024 completion date

02-May-2023 By Ben Hargreaves

Originally announced in 2021, the company expects the US facility for plasma treatments to be ready by the end of 2024.

Bristol Myers Squibb acquires US viral vector production facility from Novartis

27-Apr-2023 By Rachel Arthur

Bristol Myers Squibb will boost its cell therapy manufacturing network with in-house viral vector production thanks to the acquisition of Novartis’ Libertyville, Illinois facility.

PCI Pharma expands global sterile fill-finish capacity

25-Apr-2023 By Ben Hargreaves

The company acquires three automated sterile fill-finish machines for its facilities in San Diego and Melbourne, which are now fully operational.

Boehringer Ingelheim inaugurates largest European biotechnology development center

25-Apr-2023 By Rachel Arthur

The new €350m ($386m) biotechnology research center will help power Boehringer Ingelheim’s development of biopharmaceuticals, which account for around 50% of the company’s research pipeline.

BioMarin opens €38m expansion at Irish manufacturing site

24-Apr-2023 By Rachel Arthur

BioMarin Pharmaceutical has opened the expansion of its manufacturing plant at Shanbally, Co. Cork: with the site now able to provide end-to-end manufacturing for a number of the company’s commercial products.

Sterling Pharma Solutions granted MIA license for cGMP antibody-drug conjugate manufacturing at UK facility

20-Apr-2023 By Rachel Arthur

CDMO Sterling Pharma Solutions has been granted a Manufacturer’s Authorisation for Investigational Medicinal Products from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

Undbio to invest $100m to build US insulin manufacturing facility

17-Apr-2023 By Ben Hargreaves

The South Korean company is set to create a new facility in West Virginia to house insulin manufacturing and to deliver its insulin products in the country.

Avid Bioservices unveils mammalian cell facilities expansion

06-Apr-2023 By Rachel Arthur

Avid Bioservices, a dedicated biologics CDMO in the US, has completed two expansions within the company’s mammalian cell facilities

Meissner to build new $250m manufacturing facility in Athens, Georgia

06-Apr-2023 By Rachel Arthur

Meissner Corporation – a company which manufactures advanced microfiltration and therapeutic manufacturing systems for pharmaceutical drugs, therapeutics, biologics, and cell and gene therapies - will invest nearly $250m in a new manufacturing facility...

Eli Lilly doubles investment into Ireland manufacturing facility

03-Apr-2023 By Ben Hargreaves

IDA Ireland reveals that the pharma company is planning to up its original investment at the Limerick site by $500m.

US government announces ambitions for biomanufacturing

28-Mar-2023 By Ben Hargreaves

The White House releases a report detailing how it will harness biotechnology and biomanufacturing to address numerous societal challenges, including human health.

Takeda initiates largest ever investment in Japanese manufacturing capacity

27-Mar-2023 By Ben Hargreaves

The company will build a new manufacturing facility for plasma-derived therapies, based in Osaka, Japan.

UPS Healthcare opens logistics facility in Germany

27-Mar-2023 By Jane Byrne

UPS Healthcare says its first dedicated healthcare logistics facility in Giessen, Germany is now up and running. Up to 150 jobs have been created as a result of this operation, added the provider.

Samsung Biologics to start construction of Plant 5

20-Mar-2023 By Rachel Arthur

Samsung Biologics will begin construction of Plant 5 within the first half of this year: marking the first facility for its second Bio Campus.

UK boosts cell and gene therapy manufacturing with new facility

14-Mar-2023 By Rachel Arthur

The new Clinical Biotechnology Centre (CBC) in Bristol will expand the UK’s ability to make clinical grade products for the research and development of new cell and gene therapies.

Evonik opens new facility for pharmaceutical lipids in Germany

09-Mar-2023 By Rachel Arthur

Evonik has opened a new GMP facility to manufacture lipids for advanced pharmaceutical drug delivery applications, which is situated at the company’s site in Hanau, Germany.

Recipharm’s Arranta Bio expands RNA process development capacity by 50%

09-Mar-2023 By Jane Byrne

Arranta Bio, a Recipharm company, has doubled capacity at its Massachusetts facility for process development services supporting RNA therapeutics.

Sandoz to build new biologics production plant in Slovenia, facility will support global demand for biosimilars

09-Mar-2023 By Jane Byrne

Sandoz is set to build a new biologics production plant in Lendava, Slovenia.

Moderna chooses Oxford for UK research and manufacturing mRNA hub

06-Mar-2023 By Rachel Arthur

Moderna’s UK Innovation and Technology Centre (MITC) will be located at the Harwell Campus in Oxford, and is expected to open in 2025.

Spark breaks ground on $575m gene therapy innovation center in Philadelphia

02-Mar-2023 By Jane Byrne

Spark Therapeutics, a Roche company, has officially started work on its US$575m gene therapy innovation center in West Philadelphia. The center is expected to be completed by 2026.

PackGene breaks ground on biomanufacturing and process development facility in Houston

28-Feb-2023 By Rachel Arthur

PackGene Biotech, an adeno-associated virus (AAV) vector contract research organization (CRO) and contract development and manufacturing organization (CDMO), is expanding its US services with a new cGMP biomanufacturing and processing facility in Houston....

Daiichi Sankyo to establish Japan’s first mRNA production facility

22-Feb-2023 By Jane Byrne

Daiichi Sankyo is kitting out a plant, based near Tokyo in Kitamoto, with equipment to enable the production of an mRNA vaccine against COVID-19, according to a Nikkei Asia report.

Minaris to accelerate clinical readiness of LIfT BioSciences’ cell therapy candidate

16-Feb-2023 By Jane Byrne

Minaris Regenerative Medicine, a contract development and manufacturing organization (CDMO) for cell and gene therapies, is pairing up with LIfT BioSciences on development and manufacturing for a first-generation advanced therapy medicinal product (ATMP).

New Lonza facility set to support US biotechs in managing the path to commercialization of novel therapies

14-Feb-2023 By Jane Byrne

Switzerland headquartered Lonza said it is expanding its early development services (EDS) to North America, opening a new laboratory in Cambridge, Massachusetts (US).

Lotte Biologics has big ambitions: new CDMO industry entrant unveils growth strategy

09-Feb-2023 By Jane Byrne

The South Korean player plans to expand its recently acquired US facility, to provide contract manufacturing services for Antibody Drug Conjugates (ADC), and to add drug product fill & finish facilities to establish a foothold in the North American...

Bionova Scientific aims to quadruple GMP biologics manufacturing capacity

06-Feb-2023 By Jane Byrne

The project is the first phase of a wider strategic initiative to expand capacity and enhance end-to-end biologics development and manufacturing services at the US CDMO.

New US CDMO launched to address viral vector supply bottleneck

01-Feb-2023 By Jane Byrne

Vector BioMed, a CDMO specializing in the manufacture of lentiviral vectors, launched this week; its first financing round was led by Viking Global Investors and Casdin Capital.

Lonza: Robust industry fundamentals are supportive of growth

25-Jan-2023 By Jane Byrne

Despite an uncertain macroeconomic environment, Lonza says its ‘resilient’ business model and sustained market demand delivered a strong financial performance in 2022, in line with the Swizterland based CDMO’s outlook.

Regenxbio initiates gene therapy trial for DMD as part of its AAV therapeutics strategy for 2025

24-Jan-2023 By Jane Byrne

Regenxbio has begun recruiting for its Phase I/2 gene therapy trial in Duchenne muscular dystrophy (DMD).

Needle-free future: Tackling vaccine delivery challenges

19-Jan-2023 By Jane Byrne

Biotech company, Vaxxas, has secured a partnership agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of its needle-free vaccine-patch delivery technology for mRNA vaccines.

CBM looks to boost viral vector manufacturing capabilities in cell line deal

19-Jan-2023 By Jane Byrne

The unprecedented rise in approvals for new cell and gene therapies, and the increasing industry need for cell lines to support the production of therapeutics, has spurred US CDMO, the Center for Breakthrough Medicines (CBM), to act

US and Switzerland sign good manufacturing practice agreement

19-Jan-2023 By Rachel Arthur

An agreement between the two countries means they can use each other’s good manufacturing practice inspections of pharmaceutical manufacturing facilities and avoid the need for duplicate inspections.

UK ATMP clinical research picture remains positive despite challenging global environment

17-Jan-2023 By Jane Byrne

In 2022, the UK continued to have a signficant footprint in ATMP clinical research, with total ongoing trials increasing from 168 in 2021 to 178 in 2022, according to a new report.

Resilience to expand global footprint, collaborating on first GMP biopharma facility in UAE

17-Jan-2023 By Jane Byrne

National Resilience has secured an equity investment from Mubadala, an Abu Dhabi sovereign investor. The amount was not disclosed.

Lumen Bio: ‘We face 2023 with tremendous optimism’

16-Jan-2023 By Jane Byrne

Lumen Bioscience has been highlighting recent progress made on its clinical and regulatory journey while also announcing several funding milestones supporting the development of its therapeutics to prevent serious diarrheal diseases.

Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's

05-Jan-2023 By Jane Byrne

France headquartered CDMO, Delpharm, has expanded its pharmaceutical development services with the acquisition of the Leiden Development Centre from Dr Reddy's in the Netherlands.

Boost for Axplora’s antibody drug conjugate technology platform

15-Dec-2022 By Jane Byrne

The French National Agency for the Safety of Health Products (ANSM) has granted a pharmaceutical establishment license to Axplora’s Le Mans site.

AGC Biologics and GORE align to advance downstream purification

12-Dec-2022 By Jane Byrne

AGC Biologics and GORE PharmBio are teaming up with the goal of tackling bottlenecks in downstream antibody purification.

Emmes launches cell and gene therapy center

08-Dec-2022 By Rachel Arthur

Emmes has announced the creation of a dedicated center for cell and gene therapy research: which will focus on supporting clinical trials for the Clinical Research Organization’s (CRO) clients.

GSK, Sanofi, and Takeda align with research communities to advance Singapore's biologics manufacturing capabilities

06-Dec-2022 By Jane Byrne

Global pharma giants, GSK, Sanofi, and Takeda, are set to collaborate with Singapore-based researchers to boost innovation in local biologics and vaccines manufacturing.

Recombinant specialist Sino Biological starts building first US manufacturing facility

01-Dec-2022 By Nick Taylor

Sino Biological has begun construction of its first US-based manufacturing facility at a 53-acre life science district in Houston.

Fujifilm invests $188m in new North Carolina cell culture media facility

23-Nov-2022 By Jane Byrne

Fujifilm Corporation is to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, in the US.

BioNTech acquires GMP manufacturing site in Singapore

14-Nov-2022 By Rachel Arthur

BioNTech will create an mRNA facility in Singapore through the acquisition of a Novartis site: which will become its Regional Headquarters and production center for the Asia Pacific region.

ReiThera opens new viral vector production manufacturing facility

03-Nov-2022 By Rachel Arthur

ReiThera has received operational authorization from the Italian Medicines Agency (AIFA) to open a new production area at its facility near Rome for the large-scale production of viral vectors for vaccines and gene therapy.

Thermo Fisher adds clinical research lab as part of $97m expansion

24-Oct-2022 By Ben Hargreaves

The company opens a bioanalytical lab in the US, which offers an additional 59,000-square-feet of space to the overall facility, making it “one of the largest laboratories of its kind.”